- Income Tax Expense (Benefit)
- Effective Income Tax Rate (EITR)
- Components of Deferred Tax Assets and Liabilities
- Deferred Tax Assets and Liabilities, Classification
- Adjustments to Financial Statements: Removal of Deferred Taxes
- Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
- Adjusted Net Profit Margin
- Adjusted Total Asset Turnover
- Adjusted Financial Leverage
- Adjusted Return on Equity (ROE)
- Adjusted Return on Assets (ROA)
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Income Statement
- Common-Size Balance Sheet: Assets
- Common Stock Valuation Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Tax Expense (Benefit)
12 months ended: | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Federal | |||||||||||
State | |||||||||||
Foreign | |||||||||||
Current taxes | |||||||||||
Federal | |||||||||||
State | |||||||||||
Foreign | |||||||||||
Deferred taxes | |||||||||||
Provision for income taxes |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The analysis of the annual current and deferred income tax expenses over the five-year period from December 31, 2020, to December 31, 2024, reveals several notable trends and shifts in the taxation profile.
- Current Taxes
- There is a general increasing trend in current taxes from 2020 to 2023, beginning at $127.8 million in 2020 and peaking at approximately $1.297 billion in 2023. Following this peak, a decline is observed in 2024, with current taxes decreasing to about $1.133 billion. Despite this drop, the 2024 figure remains significantly higher than that of 2020, indicating an overall upward trend in taxable income or tax liabilities reflected in the current tax expense over the period.
- Deferred Taxes
- Deferred taxes demonstrate a contrasting pattern compared to current taxes. In 2020, deferred taxes stood at a positive $277.3 million, but from 2021 onward, the amounts became negative, indicating deferred tax assets rather than liabilities or a reversal of prior deferred tax positions. The negative values deepen from -$154.6 million in 2021 to -$536.5 million in 2023, before slightly recovering to -$348.8 million in 2024. This negative trend suggests that the company is recognizing increasing deferred tax assets, which could be due to timing differences in income recognition, tax credits, or loss carryforwards. The moderate recovery in 2024 may indicate either utilization of these deferred assets or a change in future tax expectations.
- Provision for Income Taxes
- The provision for income taxes, which encompasses both current and deferred components, generally follows the movements of the current taxes but with greater variability. Starting at $405.2 million in 2020, the provision increased slightly to $388.3 million in 2021, then surged substantially to $910.4 million in 2022. A decline occurred in 2023, reducing the provision to $760.2 million, followed by a mild increase to $784.1 million in 2024. This trend reflects both the rise in current tax liabilities and the impact of deferred tax adjustments. The large increase in 2022 likely corresponds to changes in either tax legislation, profitability, or timing differences that increase the tax expense. The subsequent decline in 2023 and slight increase in 2024 indicate some stabilization, but the provision remains at a high level compared to earlier years.
In summary, the data indicates a significant escalation in current taxes over the five years, with deferred taxes shifting from an asset position in 2020 to increasingly negative values, reflecting changes in temporary differences or tax planning strategies. The combined effect on the income tax provision is a substantial increase from 2020 to 2022, followed by partial stabilization in the final years analyzed. These patterns suggest evolving tax dynamics that likely reflect changes in operational profitability, tax legislation, and tax planning measures.
Effective Income Tax Rate (EITR)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The analysis of the tax-related financial data over the five-year period reveals several significant trends and changes in various tax components, as well as in the overall effective tax rate.
- U.S. Federal Statutory Tax Rate
- The U.S. federal statutory tax rate remained stable at 21% throughout the entire period from 2020 to 2024, showing no fluctuations or adjustments during these years.
- State Taxes, Net of Federal Benefit
- This tax component shows relative stability with minor fluctuations from 0.6% to 0.8% in the early years, dipping to 0.3% in 2023, followed by a dramatic increase to 29.5% in 2024, which marks a substantial deviation from previous years.
- Foreign Income Tax Rate Differential
- The foreign income tax rate differential started close to zero at 0.2% in 2020 but turned negative in subsequent years (-0.3% in 2021 and 2022, -0.6% in 2023), before sharply rising to 21.3% in 2024. This suggests a significant shift in foreign tax rate impacts in the last year.
- U.S. Tax on Foreign Earnings, Net of Credits
- This value decreased markedly from positive contributions in the range of 0.7% to 2.7% between 2020 and 2023 to a negative impact of -12.6% in 2024, indicating possibly unfavorable changes in foreign earnings tax treatments or credits in the final year.
- Foreign Derived Intangible Income Deduction
- There was a consistent increase in the negative impact of this deduction from -0.2% in 2020 to -1.7% in 2023, culminating in a deepened negative effect of -28.3% in 2024, highlighting growing deductions related to intangible foreign income.
- Tax Credits
- Tax credits fluctuated significantly, starting at -1.8% in 2020, reaching a low of -6.4% in 2021, rebounding slightly to -2.2% in 2022, then returning to a strong reduction of -6% in 2023 before a strikingly large negative figure of -102.9% in 2024. This indicates escalating benefits from tax credits particularly in the last year, which may be an anomaly or related to extraordinary tax positions.
- Tax Rate Change
- Tax rate changes were noted in 2020 and 2021 at -1.2% and -3.5% respectively, with no reported changes in subsequent years, suggesting stabilization after early adjustments.
- Stock Compensation (Benefit), Shortfalls, and Cancellations
- This line reflects a consistent negative impact from stock compensation-related deductions or benefits, relatively minor in earlier years (-2.3% in 2020, -0.8% in 2022 and 2023) and showing a large increase in negative percentage terms (-25.5%) in 2024.
- Long-term Intercompany Receivable Write-off
- This item appeared only in 2020 with a -1.7% effect and was not reported in later years, indicating a one-time adjustment or event.
- Uncertain Tax Positions
- These have grown steadily from 1.3% in 2020 to 11.3% in 2024, indicating an increasing recognition of tax uncertainties or contingencies over the period.
- Non-deductible AIPR&D
- This value was only reported in 2024 with a very high percentage impact of 373.8%, suggesting a substantial non-deductible research and development expense or similar item during that year.
- Intra-entity Transfer of Intellectual Property Rights
- Recorded only in 2020 at -6.7%, with no subsequent data, suggesting a significant event or transaction affecting the tax position in that year.
- Other
- This category shows minor fluctuations with 1.1% in 2020 and 2023, followed by an increase to 27.9% in 2024, reflecting other tax-related factors becoming more significant in the latest year.
- Effective Tax Rate
- The effective tax rate demonstrated variability, beginning at 13% in 2020 and slightly increasing to 14.2% in 2021, then rising notably to 21.5% in 2022 before dropping to 17.4% in 2023. In 2024, there was an extraordinary surge to 315.5%, signaling an exceptional tax event or calculation anomaly impacting the overall effective tax burden drastically.
Overall, the data shows relative stability and moderate fluctuations in tax components between 2020 and 2023, followed by large, exceptional shifts in 2024 across multiple categories, especially state taxes, foreign tax-related items, non-deductible expenses, and effective tax rate. This suggests significant tax-related changes or events occurred in 2024 that heavily influenced the company's tax profile.
Components of Deferred Tax Assets and Liabilities
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The financial data reveals several notable trends over the five-year period ending December 31, 2024. Key asset categories and liabilities exhibit fluctuations that indicate evolving operational and financial strategies.
- Tax Credit Carryforwards
- These assets decline sharply from 406,120 thousand USD in 2020 to 202,400 thousand USD in 2021, then gradually increase year-over-year to 298,300 thousand USD by 2024. This reversal after the initial drop suggests either utilization of credits or changes in tax planning strategies, followed by accruals or new credits accumulation.
- Intangible Assets
- Intangible assets rose significantly from 507,484 thousand USD in 2020 to a peak of 802,800 thousand USD in 2021, followed by a slight decline and moderate fluctuations, settling at 769,300 thousand USD in 2024. This pattern may reflect acquisitions, amortization, or impairment activities impacting their carrying value.
- Stock-Based Compensation
- Stock-based compensation shows a steady increase over the years from 89,203 thousand USD in 2020 to 164,200 thousand USD in 2024, reflecting heightened employee incentives or equity compensation programs.
- Finance Lease Liabilities
- Finance lease liabilities decreased consistently from 118,749 thousand USD in 2020 to 25,900 thousand USD in 2024, indicating a reduction in financed lease obligations, possibly through repayments or lease terminations.
- Operating Lease Assets and Liabilities
- Operating lease assets increase modestly from 65,046 thousand USD in 2020 to 81,100 thousand USD in 2021, then hover around similar levels until growing sharply to 333,500 thousand USD in 2024. Correspondingly, operating lease liabilities decrease from -63,310 thousand USD in 2020 to -27,1900 thousand USD in 2024, suggesting recognition of new operating lease right-of-use assets alongside increased related liabilities, which may indicate expanded leasing activities in 2024.
- R&D Capitalization
- Data for the initial years is missing, but from 2022, there is a sharp increase in R&D capitalization, from 438,300 thousand USD to 1,404,100 thousand USD in 2024. This substantial rise may reflect intensified investment in research and development activities capitalized as assets.
- Other Assets
- The category labeled 'Other' shows a decline from 209,838 thousand USD in 2020 to 146,600 thousand USD in 2022 and 2023, followed by a small increase to 166,100 thousand USD in 2024, indicating minor fluctuations in miscellaneous asset components.
- Gross Deferred Tax Assets and Valuation Allowance
- Gross deferred tax assets increase steadily from 1,396,440 thousand USD in 2020 to 3,161,400 thousand USD in 2024. The valuation allowance also increases negatively from -213,750 thousand USD to -272,900 thousand USD in the same period. The net effect is a rising deferred tax asset balance from 1,182,690 thousand USD to 2,888,500 thousand USD, which indicates growing expectations of tax benefits, albeit partially offset by increased valuation allowances.
- Property and Equipment
- The values recorded are negative throughout, declining from -116,955 thousand USD to -110,800 thousand USD by 2024. This consistent negative figure could represent accumulated depreciation or disposals exceeding additions to property and equipment.
- Acquired Intangibles
- Acquired intangibles maintain a negative balance that deepens from -87,025 thousand USD in 2020 to approximately -132,700 thousand USD in 2024, which could indicate amortization or impairment exceeding new acquisitions.
- Deferred Tax Liabilities and Net Deferred Tax Assets
- Deferred tax liabilities grow negatively from -299,911 thousand USD to -557,400 thousand USD, suggesting an increasing obligation or timing differences in taxable income recognition. Net deferred tax assets increase positively from 882,779 thousand USD to 2,331,100 thousand USD, reflecting a growing asset position after offsetting liabilities.
Overall, the data suggest a company that is expanding its intangible assets and capitalizing more heavily on R&D investments, while reducing certain liabilities such as finance lease obligations. The increase in deferred tax assets and the related valuation allowance indicate rising tax benefit expectations accompanied by some risk considerations. The marked increase in operating lease assets and liabilities towards the end of the period further implies a strategic shift towards leasing arrangements. Negative property and equipment figures along with acquired intangibles point to ongoing amortization and asset management efforts.
Deferred Tax Assets and Liabilities, Classification
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The financial data reveals a consistent upward trend in deferred tax assets over the five-year period from 2020 to 2024. The value of deferred tax assets starts at approximately 882.8 million US dollars at the end of 2020 and increases steadily each year, reaching around 2.33 billion US dollars by the end of 2024.
This growth signifies a significant accumulation of tax benefits that the company expects to utilize in the future. The increase in deferred tax assets may reflect growing temporary differences between the book values and tax bases of assets and liabilities or the recognition of additional tax loss carryforwards and credits.
- Trend Analysis:
-
From 2020 to 2021, the deferred tax assets increased by approximately 5.8%, indicating a modest growth phase. Subsequently, the growth accelerated significantly from 2021 to 2022 with an increase of roughly 33.5%, pointing to potentially larger temporary differences or expanded tax losses.
Between 2022 and 2023, the deferred tax assets rose sharply by about 45.3%, reflecting a substantial increase in these tax assets. The trend continues with a further increase of approximately 28.6% from 2023 to 2024.
- Implications:
-
The sustained rise in deferred tax assets suggests that the company is either incurring tax-deductible temporary differences or accumulating tax loss carryforwards, which could be expected to reduce future taxable income.
This growing deferred tax asset base might indicate increased investment in R&D or capital expenditures that provide tax benefits, or it could reflect an anticipation of higher future profitability against which these tax assets will be utilized.
Adjustments to Financial Statements: Removal of Deferred Taxes
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The financial data reveals distinct trends in asset base, equity position, and profitability over the five-year period from 2020 to 2024. Both reported and adjusted figures show growth followed by a decline in the final year, indicating changes in the company’s financial dynamics.
- Total Assets
- Reported total assets increased consistently from approximately $11.75 billion in 2020 to a peak of about $22.73 billion in 2023, before slightly declining to $22.53 billion in 2024. Adjusted total assets follow a similar pattern, rising from nearly $10.87 billion in 2020 to roughly $20.92 billion in 2023, then decreasing to $20.20 billion in 2024. The steady growth over four years suggests ongoing business expansion or asset accumulation, with a minor contraction or revaluation occurring thereafter.
- Shareholders’ Equity
- The reported shareholders’ equity displays a growth trend from about $8.69 billion in 2020 to $17.58 billion in 2023, subsequently declining to $16.41 billion in 2024. Adjusted shareholders’ equity mirrors this pattern, increasing from roughly $7.80 billion to $15.77 billion over the same period, before decreasing to $14.08 billion in 2024. The strong equity growth indicates improving net worth or retained earnings, while the decrease in the final year may reflect accumulated losses or changes in valuation adjustments.
- Net Income (Loss)
- Reported net income initially rises from approximately $2.71 billion in 2020 to a peak of $3.62 billion in 2023, but then sharply turns negative, with a loss of $535.6 million in 2024. Adjusted net income, although showing a somewhat different magnitude, follows a comparable trend: starting at nearly $2.99 billion in 2020, peaking at about $3.08 billion in 2023, and then sinking into a larger adjusted loss of $884.4 million in 2024. This transition to losses after several years of profitability suggests either one-time impairments, increased expenses, or downturns in operational performance affecting earnings.
Overall, the data depicts a phase of asset growth and equity strengthening accompanied by improving profitability until 2023, followed by a notable reversal in 2024 characterized by decreases in assets and equity alongside a shift to net losses. This suggests a potential change in the company’s operating environment or financial condition that merits further investigation.
Vertex Pharmaceuticals Inc., Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The financial data over the five-year period reveals several notable trends related to profitability, asset utilization, leverage, and returns for the company.
- Net Profit Margin
- The reported net profit margin started at a robust 43.7% in 2020 but showed a declining trend through 2021 to 2023, decreasing to 36.68%. In 2024, there was a significant downturn, resulting in a negative margin of -4.86%. The adjusted net profit margin followed a similar pattern, beginning at 48.17% in 2020, declining steadily to 31.24% in 2023, and turning negative to -8.03% in 2024. This indicates deteriorating profitability, especially in the most recent year.
- Total Asset Turnover
- The reported total asset turnover showed slight fluctuations, increasing from 0.53 in 2020 to 0.56 in 2021, then declining to 0.43 in 2023 before recovering to 0.49 in 2024. The adjusted total asset turnover displayed a similar trend but consistently remained higher than the reported figures, starting at 0.57 in 2020, peaking at 0.61 in 2021, falling to 0.47 in 2023, and increasing again to 0.55 in 2024. This suggests some variability in asset efficiency but with a slight recovery in the latest year after a mid-period dip.
- Financial Leverage
- Reported financial leverage slightly decreased from 1.35 in 2020 to 1.29 in 2023, with a subsequent rise to 1.37 in 2024. Adjusted leverage mirrored this trend with values starting at 1.39 in 2020, a decline to 1.33 in 2023, and an increase to 1.43 in 2024. The leverage remains relatively stable but shows a modest increase at the end of the period, indicating a slightly higher use of debt or financial obligations in 2024.
- Return on Equity (ROE)
- Reported ROE experienced a downward trajectory from 31.22% in 2020 to 20.59% in 2023, followed by a sharp decline to -3.26% in 2024. Adjusted ROE similarly declined from 38.3% in 2020 to 19.55% in 2023 and turned negative at -6.28% in 2024. The drop into negative territory in 2024 points to significant deterioration in shareholder returns.
- Return on Assets (ROA)
- The reported ROA decreased steadily from 23.07% in 2020 to 15.92% in 2023 and then dropped sharply to -2.38% in 2024. Adjusted ROA followed the same downward trend, starting at 27.5% in 2020, declining to 14.74% in 2023, and falling to -4.38% in 2024. This suggests reduced overall asset profitability, with a marked loss in the latest year.
Overall, the company exhibited strong profitability and efficiency in 2020, which weakened steadily over the subsequent years. Asset utilization declined mid-period but showed signs of recovery in 2024. However, leverage slightly increased towards the end of the period while both returns on equity and assets turned negative in 2024, highlighting considerable financial challenges in the most recent year.
Vertex Pharmaceuticals Inc., Financial Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Net profit margin = 100 × Net income (loss) ÷ Revenues
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net income (loss) ÷ Revenues
= 100 × ÷ =
- Reported Net Income (Loss)
- The reported net income shows an initial decrease from approximately 2.71 billion in 2020 to about 2.34 billion in 2021. This is followed by a significant increase to around 3.32 billion in 2022 and a further rise to approximately 3.62 billion in 2023. However, there is a sharp reversal in 2024, with the figure declining dramatically to a loss of roughly 536 million.
- Adjusted Net Income (Loss)
- The adjusted net income follows a somewhat similar trajectory initially, starting at about 2.99 billion in 2020, then decreasing to 2.19 billion in 2021. It rebounds to around 3.05 billion in 2022, and remains relatively stable in 2023 at approximately 3.08 billion. In 2024, it also turns negative, falling to a loss of approximately 884 million, which suggests a more pronounced negative adjustment compared to the reported figure.
- Reported Net Profit Margin
- The reported net profit margin experiences a significant decline from 43.7% in 2020 to 30.92% in 2021. It then recovers moderately, increasing to 37.2% in 2022 and slightly decreasing to 36.68% in 2023. The margin deteriorates sharply in 2024 to negative 4.86%, indicating a loss relative to revenues during that period.
- Adjusted Net Profit Margin
- The adjusted net profit margin also declines markedly from 48.17% in 2020 to 28.88% in 2021. It shows some recovery in 2022 to 34.11%, before decreasing to 31.24% in 2023. By 2024, the adjusted margin worsens substantially to negative 8.03%, which is a more severe decline than the reported margin, underscoring significant adjustments impacting profitability.
- Overall Analysis
- The data reveals a period of fluctuating profitability with an adverse trend emerging clearly in 2024. Both reported and adjusted net income and profit margins display strong performance until 2023, with 2021 showing some weakness. The transition to losses in 2024 is stark and notable, with adjusted figures indicating a heavier impact. These trends suggest that the company faced significant challenges or one-time events leading to negative earnings and profitability in the most recent year analyzed.
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Total asset turnover = Revenues ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Revenues ÷ Adjusted total assets
= ÷ =
The analysis of the reported and adjusted financial metrics over the five-year period reveals several notable trends and patterns.
- Total Assets (Reported and Adjusted)
- The reported total assets show a consistent upward trajectory from 11,751,808 thousand US dollars in 2020 to a peak of 22,730,200 thousand in 2023, followed by a slight decline to 22,533,200 thousand in 2024. This represents significant growth over the period, with the largest increase occurring between 2021 and 2022 and again between 2022 and 2023.
- The adjusted total assets follow a similar upward trend, rising from 10,869,029 thousand in 2020 to 20,918,100 thousand in 2023, before declining to 20,202,100 thousand in 2024. The adjusted figures are consistently lower than the reported values, reflecting the impact of deferred income tax adjustments. The pattern of growth and slight reduction in the final year mirrors that of the reported figures.
- Total Asset Turnover (Reported and Adjusted)
- The reported total asset turnover ratio displays a generally declining trend over the period, starting from 0.53 in 2020, peaking slightly at 0.56 in 2021, then decreasing to 0.49 in 2022, and further down to 0.43 in 2023, before an uptick to 0.49 in 2024. This suggests a decreasing efficiency in using total assets to generate revenue, with some recovery in the last year.
- The adjusted total asset turnover exhibits a similar pattern but maintains slightly higher values compared to the reported ratios each year, beginning at 0.57 in 2020 and peaking at 0.61 in 2021. It declines to 0.53 in 2022 and then to 0.47 in 2023, followed by a partial recovery to 0.55 in 2024. This indicates that after adjusting for deferred income taxes, the asset utilization efficiency is higher but still experiences the same general trend of decline and partial rebound.
Overall, the asset base shows robust growth over the period though with a slight decrease in the final year. In contrast, asset turnover ratios, both reported and adjusted, suggest a reduction in efficiency in generating revenue from assets until 2023, with some improvement occurring in 2024. The deferred income tax adjustments result in consistently lower asset values and higher turnover ratios, highlighting their influence on financial performance measurements.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Financial leverage = Total assets ÷ Shareholders’ equity
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted shareholders’ equity
= ÷ =
- Total Assets
- The reported total assets exhibit a consistent upward trend from 11.75 billion US dollars in 2020 to a peak of 22.73 billion in 2023, followed by a slight decrease to 22.53 billion in 2024. Adjusted total assets follow a similar pattern, increasing from 10.87 billion in 2020 to 20.92 billion in 2023, then declining modestly to 20.20 billion in 2024. This indicates significant asset growth over the five-year period with a minor reduction towards the end.
- Shareholders’ Equity
- Reported shareholders’ equity grows steadily from 8.69 billion in 2020 to a high of 17.58 billion in 2023, then decreases to 16.41 billion in 2024. Adjusted shareholders’ equity follows this pattern as well, rising from 7.80 billion to 15.77 billion between 2020 and 2023 before dropping to 14.08 billion in 2024. The equity growth aligns with asset increases, but the reduction in equity in 2024 may suggest either increased liabilities or valuation adjustments.
- Financial Leverage
- Reported financial leverage ratios show a slight decline from 1.35 in 2020 to 1.29 in 2023, indicating a gradual reduction in leverage, followed by an increase to 1.37 in 2024. Adjusted financial leverage similarly decreases from 1.39 to 1.33 between 2020 and 2023, then rises to 1.43 in 2024. The increase in leverage in the latest period suggests a relatively higher level of debt or other liabilities compared to equity after adjustments.
- Overall Insights
- The data reveals a general growth in the company's asset base and equity over the five-year span up to 2023, accompanied by a reduction in financial leverage, highlighting a strengthening capital structure. However, in 2024, the trends reverse slightly, with minor decreases in assets and equity and an increase in financial leverage, potentially indicating a strategic shift in financing or operational challenges. The adjustments for annual reported and deferred income tax demonstrate consistent patterns but also reflect slightly higher leverage when adjusted figures are considered, emphasizing the importance of these adjustments in understanding the financial position.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 ROE = 100 × Net income (loss) ÷ Shareholders’ equity
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net income (loss) ÷ Adjusted shareholders’ equity
= 100 × ÷ =
- Net Income Analysis
- The reported net income exhibits an increase from 2,711,647 thousand US dollars in 2020 to a peak of 3,619,600 thousand US dollars in 2023, followed by a significant decline to a loss of 535,600 thousand US dollars in 2024. Similarly, the adjusted net income rises from 2,988,988 thousand US dollars in 2020 to a high of 3,083,100 thousand US dollars in 2023, before falling sharply to a loss of 884,400 thousand US dollars in 2024. This pattern indicates a period of growth culminating in 2023, succeeded by a notable downturn in 2024.
- Shareholders’ Equity Analysis
- Reported shareholders’ equity shows a consistent upward trend from 8,686,815 thousand US dollars in 2020 to 17,580,400 thousand US dollars in 2023, with a slight decrease to 16,409,600 thousand US dollars in 2024. Adjusted shareholders’ equity follows a similar trajectory, increasing from 7,804,036 thousand US dollars in 2020 to 15,768,300 thousand US dollars in 2023, then declining to 14,078,500 thousand US dollars in 2024. This indicates strong equity growth over the four-year period, overshadowed by a moderate reduction in the final year.
- Return on Equity (ROE) Analysis
- Reported ROE decreases steadily from 31.22% in 2020 to 20.59% in 2023, then turns negative at -3.26% in 2024, reflecting diminished profitability relative to equity and eventual losses. Adjusted ROE similarly declines from 38.3% in 2020 to 19.55% in 2023, with a further drop to -6.28% in 2024. The consistent downward trend culminating in negative returns highlights deteriorating efficiency in generating profits for shareholders.
- Summary of Trends
- Over the observed period, both reported and adjusted net income demonstrate initial growth through 2023, followed by a sharp reversal to net losses in 2024. Shareholders’ equity increases significantly until 2023, supporting growth, but experiences a decline in the subsequent year. Return on equity metrics indicate a weakening return on invested capital over time, turning negative in the final year. Collectively, these patterns suggest a phase of positive financial performance disrupted by adverse conditions in 2024, impacting profitability and equity returns, with equity base showing resilience but some contraction.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 ROA = 100 × Net income (loss) ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net income (loss) ÷ Adjusted total assets
= 100 × ÷ =
- Net Income Trends
- The reported net income exhibited fluctuations over the analyzed period, initially declining from approximately 2.71 billion in 2020 to 2.34 billion in 2021, then rising significantly to reach a peak of 3.62 billion in 2023 before sharply turning negative with a loss of 535.6 million in 2024. The adjusted net income follows a similar trajectory, although the decline in 2021 was more pronounced, dropping to about 2.19 billion, and the loss in 2024 was even larger at 884.4 million. These patterns suggest increasing volatility in profitability, culminating in substantial losses in the most recent year for both reported and adjusted figures.
- Asset Size and Growth
- Both reported and adjusted total assets showed consistent growth over the first four years, with reported assets increasing from approximately 11.75 billion in 2020 to a peak of 22.73 billion in 2023 before a slight decline to 22.53 billion in 2024. Adjusted total assets exhibited a comparable pattern, rising steadily from 10.87 billion to 20.92 billion over the same timeframe, followed by a reduction to 20.20 billion in 2024. The robust asset growth suggests significant expansion or investment activities during the period, though the modest contraction in 2024 may indicate some asset divestitures or revaluations.
- Return on Assets (ROA)
- The reported ROA decreased from a high of 23.07% in 2020 to 17.44% in 2021, followed by a slight recovery in 2022 to 18.3%, and subsequent decline to 15.92% in 2023. In 2024, the ROA turned negative (-2.38%), reflecting the net loss during that year. Adjusted ROA demonstrated a similar trend but with more pronounced fluctuations, starting at 27.5% in 2020, dropping to 17.5% in 2021, a minor decrease to 18.02% in 2022, then a decline to 14.74% in 2023, and turning sharply negative to -4.38% in 2024. This decline in profitability relative to asset base underscores deteriorating operational efficiency or increased expenses impacting returns in the latest period.
- Overall Assessment
- The financial data reveals an initial period of asset growth and solid returns on assets through 2023, accompanied by generally positive net income. However, the transition into 2024 shows a marked shift: net income turned negative, total assets slightly decreased, and ROA moved into negative territory. The adjusted figures corroborate these observations, indicating that after-tax financial adjustments did not materially alter the trend of declining profitability and returns in the final year under review. This pattern suggests emerging challenges affecting profitability and asset performance that warrant further investigation and monitoring.